Clinical Trial Detail

NCT ID NCT03682055
Title Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cullinan Apollo Corporation
Indications

nasopharynx carcinoma

Therapies

VK-2019

Age Groups: adult senior

No variant requirements are available.